Answers are grounded in this paper and cite their sources.
Small plastic particles (microplastics, defined as < 5 mm in size, and nanoplastics, < 1 µm [1000 nm] in size) are now ubiquitous environmental contaminants with increasing relevance to dermatology. These plastics originate from personal care products, synthetic textiles, packaging, and degradation of consumer plastics, resulting in human exposure through air, water, diet, and direct skin contact. These particles are no longer considered environmentally inert, with detection in human tissues and growing evidence linking exposure to inflammatory and cardiometabolic diseases, including atherosclerotic plaque burden and increased cardiovascular risk. For dermatology, concern centers on emerging evidence that small plastic particles and plastic-associated chemicals may have distinct or overlapping effects relevant to inflammatory skin diseases, including atopic dermatitis, psoriasis, hidradenitis suppurativa, and related barrier and immune-mediated disorders. The skin represents a primary interface for environmental exposures, as more than 90% of personal care products are applied directly to the skin, and polymer-based ingredients remain widespread despite partial regulatory bans. This review covers current evidence on cutaneous exposure pathways, biologic mechanisms, clinical relevance, and global policy considerations related to small plastic particles. Experimental studies suggest that micro- and nanoplastics may adhere to the stratum corneum, accumulate within follicular structures, and penetrate epidermal layers under certain conditions, particularly when the skin barrier is disrupted. The extent of penetration across intact human skin and subsequent systemic absorption remains unclear. Plastics may also act as carriers for endocrine-disrupting chemicals, metals, and microbes. Emerging data suggests potential relevance to inflammatory skin conditions, microbiome disruption, and occupational skin disease. Dermatology is uniquely positioned to address this issue through patient education, exposure-aware clinical practice, research, and advocacy. Integrating consideration of small plastic particle exposure into dermatologic care and research represents an important opportunity to advance environmental health, prevention, and health equity within the field.
No takes yet. Share an insight, caveat, or question.
Tan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: